Could clearing old cells boost brain and body in MS patients?

NCT ID NCT07270120

Not yet recruiting Symptom relief Sponsor: Ohio State University Source: ClinicalTrials.gov ↗

First seen Dec 08, 2025 · Last updated May 23, 2026 · Updated 22 times

Summary

This early-stage study tests whether a combination of two drugs (dasatinib and quercetin) is safe and can help improve physical and thinking abilities in older adults with secondary progressive multiple sclerosis (MS). The drugs work by removing aged, damaged cells that may fuel inflammation and slow nerve repair. The study enrolls 30 people aged 50-85 who are not on MS therapies and have worsening symptoms. Participants take the drugs every two weeks for three months and are followed for one year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS (MS) SECONDARY PROGRESSIVE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Ohio State Martha Morehouse Outpatient Care

Columbus, Ohio, 43210, United States

Contact Phone: •••-•••-••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MULTIPLE SCLEROSIS (MS) SECONDARY PROGRESSIVE